This content is machine translated Atrial fibrillation Anticoagulation in Atrial Fibrillation – A Brief Update. Oral anticoagulation with the non-vitamin K-dependent oral anticoagulants (NOAKs) in patients with atrial fibrillation is a success story. Since the introduction of these substances in Switzerland almost 10 years ago,…
View Post 3 min This content is machine translated Off-label use of dupilumab 16-year-old can breathe again Physicians from the Department of Otorhinolaryngology at the University Hospital of Giessen and Marburg were dealing with a 16-year-old patient with a particularly pronounced chronic rhinosinusitis with nasal polyps (CRScNP)…
View Post 6 min This content is machine translated CAR-T Cells Own immune cell as therapy With the rapid development of new therapeutic options in oncology, immunotherapy has a high priority. Thus, CAR T cells are also a promising approach to treat advanced cancers. In particular,…
View Post 5 min This content is machine translated Chronic urticaria In which cases do the guidelines recommend omalizumab? According to the guidelines, omalizumab can be used if therapy with dosed H1 antihistamines does not lead to sufficient relief of symptoms. There is ample evidence of efficacy for this…
View Post 4 min This content is machine translated Interstitial lung disease Exemplary diagnostics of IPF The range of interstitial lung disease is wide. Therapeutic progress has been made in many areas over the past decade. In idiopathic pulmonary fibrosis (IPF), there was virtually no way…
View Post 11 min This content is machine translated Sideropenia Iron deficiency in the oncological patient Worldwide, iron deficiency is the most common deficiency disease. In Europe, the prevalence is 5-10% and is one of the most common causes of anemia, accounting for about 50%. An…
View Post 10 min This content is machine translated Rarer tumor entities Current therapeutic options in metastatic renal cell carcinoma. Renal cell carcinoma is one of the rather rare tumor entities. Therefore, treatment options were very limited for years and therapy was difficult. Meanwhile, tyrosine kinase inhibitors have expanded the…
View Post 4 min This content is machine translated Infections of the lower respiratory tract Does RSV have causal influence on “wheezing illnesses”? Lower respiratory tract infections (LRTIs) caused by respiratory syncytial virus (RSV) contribute significantly to morbidity and mortality in infants 0 to 1 years of age. Although there is a well-documented…
View Post 5 min This content is machine translated Moderate to severe psoriasis “A clear future” – expectations for biologics have risen An improved understanding of the pathogenesis of psoriatic diseases has contributed to a new generation of biologics in recent years. The currently approved modern representatives of this group of system…
View Post 2 min This content is machine translated Paroxymal Nocturnal Hemoglobinuria (PNH) Ravulizumab now reimbursable The first approved long-acting complement inhibitor for patients with PNH, ravulizumab, has been approved for nationwide reimbursement by the federal health department. This gives adult PNH patients in Switzerland access…
View Post 4 min This content is machine translated Asthma therapy with SCS A good option – but not for everyone Short-term administration of systemic corticosteroids (SCS) is an effective and fast-acting option to resolve acute asthma symptoms, including exacerbations. Early administration of SCS to treat severe seizures is considered standard,…
